Topics

DARTS Sciences, Inc. Company Profile

04:20 EST 23rd January 2020 | BioPortfolio


News Articles [569 Associated News Articles listed on BioPortfolio]

Clarivate Analytics expanded IP data leadership by new acquisition of the leading provider of intellectual property case law and analytics Darts-ip

Clarivate Analytics expanded IP data leadership by new acquisition of the leading provider of intellectual property case law and analytics Darts-ip   Global IP Guideline Document by World Intelle...

The Azitra approach: Treating disease targets with microbial darts

If I were to ask you to imagine someone with “cancer,” you’d probably imagine a hairless face. And while hair loss may be the universally recognizable side effect of cancer treatment, patients o...

iHealthRecord makes a good case for PHR

Christina over at Christina’s Considerations writes about Personal Health Records. She points out Medem’s new iHealthRecord site, which seems like a great PHR initiative. This PHR competes...

Ben-Gurion U. and Salk Institute Researchers awarded $14.3 million NIH grant

(American Associates, Ben-Gurion University of the Negev) The five-year research project will provide a better understanding of how the brain controls movement, as well as how neurological diseases an...

Almac Sciences: Company Activity and Sharing Risks in Collaborations

In this episode of PharmaTelevision News Review, Fintan Walton talks with Denis Geffroy, Vice President Business Development at Almac Sciences at Almac. Filmed at BioTrinity 2010 in Newbury, UK, they ...

SDP exercises option to acquire five Roivant divisions; forms Sumitovant to run them

Sumitomo Dainippon Pharma Co. Ltd. (SDP) paid $3bn in cash to exercise its previously announced option to acquire five Roivant Sciences Inc. biopharmaceutical divisions (known as vants). The five comp...

DGAP-Adhoc: Xlife Sciences AG: Xlife Sciences emittiert Wandelanleihe (deutsch)

Xlife Sciences AG: Xlife Sciences AG emittiert Wandelanleihe DGAP-Ad-hoc: Xlife Sciences AG / Schlagwort(e): Anleiheemission Xlife Sciences AG: Xlife Sciences AG emittiert Wandelanleihe 25.11.2019 ...

GB Sciences (OTCQB: $GBLX) Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master Research and Development Agreement

LAS VEGAS - November 18, 2019 (Investorideas.com Newswire) GB Sciences, Inc. (OTCQB: GBLX) completed the sale on November 15, 2019 of its 50% membership interest in GB Sciences Louisiana, LLC to Wellc...

Drugs and Medications [45 Associated Drugs and Medications listed on BioPortfolio]

Mondoxyne [oculus innovative sciences]

Mondoxyne NL 50mg

Mondoxyne nl 100mg [oculus innovative sciences]

Monodoxyne NL 100mg

Deltasone [oculus innovative sciences]

Deltasone 20mg prednisone tablets

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir dis...

Emtriva [gilead sciences, inc.]

These highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule, for oral use EMTRIVA (e...

PubMed Articles [565 Associated PubMed Articles listed on BioPortfolio]

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction.

Drug Affinity Responsive Target Stability (DARTS) is a robust method for detection of novel small molecule protein targets. It can be used to verify known small molecule-protein interactions and to fi...

Therapeutic Applications of Ethanol: A Review.

To review knowledge on therapeutic uses of ethanol and the latter's effectiveness and safety profiles in a range of indications.

Drosophila flies in the face of aging.

Testing the Geroscience Hypothesis: Early Days.

Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis.

We evaluated the effectiveness and safety of various multitarget therapies for inducing remission in lupus nephritis patients.

Clinical Trials [267 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

Dietary Pattern and Metabolic Health Study

This is a single-blind, randomized trial. Based on inclusion and exclusion criteria, 450 eligible volunteers, who were 25-60 years old, with overweight/obese and prediabetes are assigned t...

Companies [1139 Associated Companies listed on BioPortfolio]

DARTS Sciences, Inc.

DARTS

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

T.A. Sciences

T.A. Sciences www.TASciences.com is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...

More Information about "DARTS Sciences, Inc." on BioPortfolio

We have published hundreds of DARTS Sciences, Inc. news stories on BioPortfolio along with dozens of DARTS Sciences, Inc. Clinical Trials and PubMed Articles about DARTS Sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DARTS Sciences, Inc. Companies in our database. You can also find out about relevant DARTS Sciences, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record